Title : A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan.

Pub. Date : 2013

PMID : 23328486






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan. Irinotecan KRAS proto-oncogene, GTPase Homo sapiens
2 OBJECTIVES: We conducted a phase II clinical trial of high-dose cetuximab plus irinotecan in KRAS wild-type patients who progressed on standard-dose cetuximab plus irinotecan. Irinotecan KRAS proto-oncogene, GTPase Homo sapiens